Injective (INJ) is 2.8× the size of Tezos (XTZ) by market capitalisation. Over the past 1 year, INJ is ahead by 61.1 percentage points (XTZ -53.6% against INJ +7.5%). Their daily returns move closely together (correlation 0.65 across 399 shared trading days). INJ has been the more volatile of the two, at 100% annualised against XTZ's 75%.
XTZINJ
0.65over 399 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | XTZ | INJ |
|---|---|---|
| Max drawdown (400d) | -72.9% | -79.5% |
| Risk-adjusted return (90d) | 0.29 | 0.46 |
| Best 30 days (past year) | +65.7% | +92.8% |
| Worst 30 days (past year) | -42.6% | -46.8% |
Relative strength over 90 days: INJ outperformed XTZ by 15.7% — measured on the XTZ/INJ ratio, so it holds regardless of market direction.